Form D · Pharmaceuticals
ISIS PHARMACEUTICALS INC
Carlsbad, CA · CIK 0000874015
Offering snapshot reported Aug 27, 2012 · SEC filing
- Reported sold
- $201M Offering amount: $201M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 13, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2012 | Initial | $201,250,000 | No comparison | 5 | SEC filing |
| Apr 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-183295
Represents the aggregate principal amount of 2-3/4% Convertible Senior Notes due 2019, which were sold to the initial purchasers at a 3% discount from the aggregate principal amount.
Source: Form D, filed Aug 27, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| C Frank Bennett | Executive |
| Spencer R Berthelsen | Director |
| Stanley T Crooke | Director, Executive |
| Richard S Geary | Executive |
| Joseph Klein Iii | Director |
| Brett P Monia | Executive |
| Frederick T Muto | Director |
| B Lynne Parshall | Director, Executive |
| John C Reed | Director |
| Joseph H Wender | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2855 Gazelle Court
Carlsbad, CA, 92010
Carlsbad, CA, 92010